Jeremy J. Edmunds - Concepedia

Author

Jeremy J. Edmunds

Also Known As

Edmunds, J.J., Edmunds, Jeremy J., J. Edmunds, J. J. EDMUNDS, J.J. Edmunds, JEREMY J. EDMUNDS, Jeremy Edmunds, Jeremy J Edmunds, Jeremy J. Edmunds

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)AbbVie (United States)NAEJA-RGM Pharmaceuticals (Canada)Colorado State University Northwestern University

About

Jeremy J. Edmunds is an author at Pfizer (United States) specializing in drug discovery, medicinal chemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	37	1K
2	Natural Sciences	20	32	962
3	Biochemistry	18	28	757
4	Engineering	9	9	279
5	Applied Physics	1	1	28

Jeremy J. Edmunds

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa J. Adam Willardsen, Danette A. Dudley, Wayne L. Cody, Journal of Medicinal Chemistry	2004	121
Discovery of a Novel Series of Orally Active Non-Peptide Endothelin-A (ETA) Receptor-Selective Antagonists Annette M. Doherty, William C. Patt, Jeremy J. Edmunds, Journal of Medicinal Chemistry ImmunologyAltmetric Attention ScorePeptide SciencePharmacotherapyPre-clinical Pharmacology	1995	109
Cheminformatic Tools for Medicinal Chemists Steven W. Muchmore, Jeremy J. Edmunds, Kent D. Stewart, Journal of Medicinal Chemistry Combinatorial ChemistryPharmaceutical ScienceCheminformatic ToolsAltmetric Attention ScoreChemistry	2010	83
A versatile copper-catalyzed coupling reaction of pyridin-2(1H)-ones with aryl halides Kevin J. Filipski, Jeffrey T. Kohrt, Agustin Casimiro‐Garcia, Tetrahedron Letters Aryl HalidesChemical EngineeringCross-coupling ReactionEngineeringOrganic Chemistry	2006	56
Discovery of a Series of Imidazo[4,5-<i>b</i>]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ Agustin Casimiro‐Garcia, Gary F. Filzen, Declan Flynn, Journal of Medicinal Chemistry	2011	52
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors Noel A. Powell, Fred L. Ciske, Cuiman Cai, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryRational DesignNatural SciencesMedicine	2007	52
Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors Danette A. Dudley, Amy Bunker, Liguo Chi, Journal of Medicinal Chemistry Combinatorial ChemistryInappropriate Thrombus FormationOrganic ChemistryHeterocycle ChemistryMolecular Pharmacology	2000	49
Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists William C. Patt, Jeremy J. Edmunds, Joseph T. Repine, Journal of Medicinal Chemistry Selective Antagonist Pd155080Pharmaceutical ScienceChemical BiologyExperimental PharmacologyMolecular Pharmacology	1997	46
Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit Dawn M. George, Eric C. Breinlinger, Michael Friedman, Journal of Medicinal Chemistry Drug TargetImmunologyPharmacotherapyT CellsPharmaceutical Chemistry	2014	42
Applications of crotyldiisopinocampheylboranes in synthesis: a formal total synthesis of (+)-calyculin A Oren P. Anderson, Anthony G. M. Barrett, Jeremy J. Edmunds, Canadian Journal of Chemistry Chemical EngineeringBioorganic ChemistryEngineeringBiochemistryNatural Sciences	2001	40

Page 1